XAIR Earnings

XAIR reported its FY2026Q3 earnings on 2026-02-13, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following XAIR's FY2026Q3 earnings announcement on 2026-02-13, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, XAIR's stock price tends to shift by an average of -6.64% in the 10 days leading up to earnings and -22.93% in the 10 days following, providing insight into potential market.

For 2026/Q3, analysts estimate XAIR’s annual revenue to reach 2.00M, while the EPS is projected at -1.00. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates Revise Downward by -31.15% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between XAIR's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were No Change by 0%, while EPS estimates moved Revise Downward by -31.15% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, XAIR's stock price typically moves by -6.64% in the 10 days before its earnings and -22.93% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of -1.00 and revenue of 2.00M.

The earnings call summary indicates strong financial performance with a 128% YoY revenue increase, reduced gross losses, and significant cost reductions. The Q&A section reveals positive sentiment towards the second-gen LungFit PH, expected to drive further growth, despite supply chain challenges. The company's strategic international expansion and new business model also contribute positively. However, the vague management responses and updated guidance suggest some uncertainty, tempering the overall sentiment. Considering these factors, the stock price is likely to experience a positive movement, especially given the significant revenue growth and cost control.